Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fidler

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
British Journal of Clinical Pharmacology|January 19, 2007
Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusionMeredith C Fidler, Bruce A Barshop, Jon A Gangoiti, et al.
The Journal of Pathology|July 27, 1999
Gene rearrangements in T-cell lymphoblastic lymphomaE Pilozzi, H K Müller-Hermelink, B Falini, et al.
The Journal of Clinical Endocrinology and Metabolism|July 29, 2011
A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trialMeredith C Fidler, Matilde Sanchez, Brian Raether, et al.
Genomics|February 1, 1994
Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpointJ Boultwood, C Fidler, S Lewis, et al.
Genomics|June 14, 2000
Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAsJ Boultwood, C Fidler, A J Strickson, et al.
British Journal of Cancer|March 18, 2004
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCRS Gal, C Fidler, Y M D Lo, et al.
Blood|November 1, 1993
Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndromeJ Boultwood, C Fidler, S Lewis, et al.
Blood|July 13, 2000
Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phaseJ Boultwood, A Peniket, F Watkins, et al.
American Journal of Hematology|December 12, 1997
Telomere length in myelodysplastic syndromesJ Boultwood, C Fidler, R Kusec, et al.
Leukemia|February 25, 2006
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemiaL J Campbell, C Fidler, H Eagleton, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
British Journal of Clinical Pharmacology|January 19, 2007
Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusionMeredith C Fidler, Bruce A Barshop, Jon A Gangoiti, et al.
The Journal of Pathology|July 27, 1999
Gene rearrangements in T-cell lymphoblastic lymphomaE Pilozzi, H K Müller-Hermelink, B Falini, et al.
The Journal of Clinical Endocrinology and Metabolism|July 29, 2011
A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trialMeredith C Fidler, Matilde Sanchez, Brian Raether, et al.
Genomics|February 1, 1994
Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpointJ Boultwood, C Fidler, S Lewis, et al.
Genomics|June 14, 2000
Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAsJ Boultwood, C Fidler, A J Strickson, et al.
British Journal of Cancer|March 18, 2004
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCRS Gal, C Fidler, Y M D Lo, et al.
Blood|November 1, 1993
Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndromeJ Boultwood, C Fidler, S Lewis, et al.
Blood|July 13, 2000
Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phaseJ Boultwood, A Peniket, F Watkins, et al.
American Journal of Hematology|December 12, 1997
Telomere length in myelodysplastic syndromesJ Boultwood, C Fidler, R Kusec, et al.
Leukemia|February 25, 2006
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemiaL J Campbell, C Fidler, H Eagleton, et al.
Pageof 6